Summary
This SEC filing on Form 6-K for CRH Public Limited Company (CRH) reports on the grant of share options and awards to several key executives, including Directors and Persons Discharging Managerial Responsibility. The transactions, which occurred on April 4, 2011, involve grants under the CRH 2010 Share Option Scheme and the CRH 2006 Performance Share Plan. These grants are a standard component of executive compensation designed to align management's interests with those of shareholders by providing incentives for future company performance. Investors should note that these grants have specific exercise periods and prices for the options, and performance conditions for the awards. The exercise price for the 2010 Share Option Scheme grants is €16.38, with an exercise period from April 2014 to April 2021. The Performance Share Plan awards have varying vesting schedules between March 2014 and April 2015. This filing provides transparency into the company's compensation practices and potential future share dilution.
Key Highlights
- 1Multiple CRH Directors and Persons Discharging Managerial Responsibility (PDMRs) were granted share options and performance share awards on April 4, 2011.
- 2The grants include options under the CRH 2010 Share Option Scheme with an exercise price of €16.38 per share.
- 3Performance Share Awards were also granted under the CRH 2006 Performance Share Plan, with vesting tied to performance conditions.
- 4Share options from the 2010 scheme have a typical exercise window between April 2014 and April 2021.
- 5Performance Share Plan awards are structured to vest between March 2014 and April 2015, indicating a medium-term performance focus.
- 6These grants are part of the company's executive compensation strategy to incentivize management and align their interests with shareholders.
- 7The filing details the specific number of ordinary shares involved in each grant for each executive.